Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Jubilant Pharmova Ltd - 530019 - Jubilant Pharmova - Q3 FY 2022 Results

 In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2021 were approved by the Board of Directors of the Company at its meeting held today at 12.15 p.m. and concluded at 3.20 p.m. Pursuant to the applicable provisions of the Listing Regulations, we enclose the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2021; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and 3. Copies of the Press Release and Presentation. We request you to take the same on records.
04-02-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by Mr. Snehal Ramesh Shah claiming to be the legal heir of the shareholder as per the attachment. Mr. Snehal Ramesh Shah has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the legal heir on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
01-02-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Schedule Of Investor Conference Call For Jubilant Pharmova Limited - Unaudited Financial Results For The Quarter Ended December 31, 2021

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on February 4, 2022 after submission of the financial results for the quarter ended December 31, 2021 to the Stock Exchanges. Details of the Conference Call are attached. This is for information and record.
27-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Intimation Of Board Meeting - February 4, 2022

 Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 4, 2022, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2021. This is for your information and record.
27-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Shareholding for the Period Ended December 31, 2021

 Jubilant Pharmova Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
20-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that share certificates have been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificates in lieu of the original. We propose to issue Duplicate Share Certificates to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
19-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Jubilant Pharmova Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
17-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Outcome Of NCLT Convened Meetings

 Outcome of NCLT Convened Meetings of Equity Shareholders and Unsecured Creditors of the Company
15-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0321 Name of the Signatory :- Rajiv ShahDesignation :- Company Secretary and Compliance Officer
11-01-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are enclosing a Confirmation Certificate for the quarter ended December 31, 2021 received from M/s Alankit Assignments Limited, Registrar and Share Transfer Agent of the Company.
11-01-2022
Next Page
Close

Let's Open Free Demat Account